Non-cardiac Chest Pain
9
0
2
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
22.2%
2 terminated out of 9 trials
66.7%
-19.9% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (9)
One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care
iCBT for Cardiac Anxiety in Patients With NCCP
Internet-delivered CBT for Patients With NCCP
Validation of the Panic Screening Score in Patient With Unexplained Chest Pain
Non-cardiac Chest Pain Evaluation and Treatment Study (CARPA) - Part 1: Diagnosis.
Treatment Study Comparing Manual Treatment or Advice in Acute, Musculoskeletal Chest Pain
Evaluation of Patients With Non-cardiac Chest Pain
The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients
Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP patientsChinese?